Mustacchi, G <br/><br/>
Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients.  [electronic resource] 

 -  Future oncology (London, England)  2015 
 - 1493-500 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1744-8301 
<br/><br/><label>Standard No.: </label>10.2217/fon.15.34  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--pharmacology<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Italy<br/>Middle Aged<br/>Neoplasm Staging<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Survival Analysis<br/>Trastuzumab--pharmacology<br/>Treatment Outcome